Hidradenitis suppurativa
☆ I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
Hidradenitis suppurativa (tulaga I) i le lima. Ose tulaga la'ititi tele lea ole Hidradenitis suppurativa.
References
Hidradenitis suppurativa ose ma'i pa'u e tumau, e toe fo'i mai pea, ma e ono afaina tele ai lou olaga. E mafua ona o le fulafula i le follicles o lauulu, ma e masani ona oo atu ai i siama siama. E masani ona su'esu'eina e foma'i e ala i le va'ava'ai i ituaiga papala e te maua (pei o nodules, abscesses, po'o sinus tracts) , o fea oi ai (masani i ga'u pa'u) , ma pe fa'afia ona toe fo'i mai ma le umi e pipii ai.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
O togafitiga e le fa'aolaola ma le le fa'atinoina e masani ona fa'aoga na'o ia mo fa'ama'i vaivai ma e mafai ona tu'ufa'atasia ma togafitiga fa'aolaola ma taotoga mo fa'ama'i feololo i ma'i tuga. O suʻesuʻega talu ai nei e maua ai faʻamaoniga faʻaopoopo o le aoga mo le faʻaogaina o corticosteroids tuʻi saʻo i totonu o faʻamaʻi mo le HS flare-ups ma faʻalavelave faʻapitonuʻu. E lē gata i lea, o lo'o iai fa'amaoniga e fa'ailoa mai ai o le fa'aaogaina na'o le tetracyclines e mafai ona tutusa lelei ma le tu'ufa'atasia o le clindamycin ma le rifampicin.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
O le tele o togafitiga e faʻaaogaina mo le hidradenitis suppurativa, e aofia ai vailaʻau faʻamaʻi, retinoids, antiandrogens, vailaʻau e puipuia ai le puipuia, vailaʻau faʻamaʻi, ma le radiotherapy mo manua vave. O togafitiga pito sili ona fautuaina o le adalimumab ma le laser therapy. Ta'otoga, pe fa'ato'a faigofie po'o le fa'ato'a fa'amama fa'alotoifale fa'atasi ma le su'iina o le pa'u, o le filifiliga sili lea mo ma'i ogaoga, ma'i e le tali lelei i isi togafitiga.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Ole mafua'aga tonu e masani ona le manino, ae talitonu e aofia ai le tu'ufa'atasiga o mea tau kenera ma le si'osi'omaga. E tusa ma le tasi vaetolu o tagata e maua i le faʻamaʻi o loʻo i ai se tagata o le aiga ua aʻafia. O isi tulaga lamatia e aofia ai le puta ma le ulaula. O le ma'i e le mafua mai i se fa'ama'i, leaga o le tumama.
E leai se fofo ua iloa. O le tipiina o manu'a e fa'ataga ai latou e fa'afefe e le maua ai se fa'amanuiaga taua. E ui e masani ona faʻaaogaina vailaau faʻamaʻi, o faʻamaoniga mo lo latou faʻaaogaina e le lelei. E mafai fo'i ona fa'ata'ita'i vaila'au fa'ama'i. I latou e sili atu le ogaoga o faʻamaʻi, togafitiga leisa poʻo taotoga e aveese ai le paʻu o loʻo aʻafia e ono mafai. E seasea ona tupu se ma'i pa'u ma avea ma kanesa o le pa'u.
Afai o loʻo aofia ai mataupu mama o hidradenitis suppurativa , o le faʻatusatusaina o lona taimi e mai le 1-4% o le faitau aofaʻi. E faatoluina le maua o fafine i le ma'i nai lo alii. O le amataga e masani lava i le talavou matua.